Correlation Between ProMIS Neurosciences and Biotron

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ProMIS Neurosciences and Biotron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProMIS Neurosciences and Biotron into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProMIS Neurosciences and Biotron Limited, you can compare the effects of market volatilities on ProMIS Neurosciences and Biotron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProMIS Neurosciences with a short position of Biotron. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProMIS Neurosciences and Biotron.

Diversification Opportunities for ProMIS Neurosciences and Biotron

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between ProMIS and Biotron is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding ProMIS Neurosciences and Biotron Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotron Limited and ProMIS Neurosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProMIS Neurosciences are associated (or correlated) with Biotron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotron Limited has no effect on the direction of ProMIS Neurosciences i.e., ProMIS Neurosciences and Biotron go up and down completely randomly.

Pair Corralation between ProMIS Neurosciences and Biotron

Considering the 90-day investment horizon ProMIS Neurosciences is expected to under-perform the Biotron. But the stock apears to be less risky and, when comparing its historical volatility, ProMIS Neurosciences is 15.35 times less risky than Biotron. The stock trades about -0.16 of its potential returns per unit of risk. The Biotron Limited is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  1.00  in Biotron Limited on November 4, 2024 and sell it today you would earn a total of  3.97  from holding Biotron Limited or generate 397.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy90.91%
ValuesDaily Returns

ProMIS Neurosciences  vs.  Biotron Limited

 Performance 
       Timeline  
ProMIS Neurosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProMIS Neurosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Biotron Limited 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Biotron Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Biotron reported solid returns over the last few months and may actually be approaching a breakup point.

ProMIS Neurosciences and Biotron Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ProMIS Neurosciences and Biotron

The main advantage of trading using opposite ProMIS Neurosciences and Biotron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProMIS Neurosciences position performs unexpectedly, Biotron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will offset losses from the drop in Biotron's long position.
The idea behind ProMIS Neurosciences and Biotron Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios